GlobeNewsWire
15 Jul 2026, 11:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Profound Medical's TULSA Procedure has been selected as one of only eight companies to be spotlighted during the Society of Incisionless Surgery (SIS) plenary session at SRS2026. — Selection as a top-eight company in a specialized surgical society session suggests high clinical validation and competitive differentiation.
+0.40Profound Medical's management will participate in an investor session on July 22, 2026, moderated by analysts from Stifel Financial and Wells Fargo. — Direct engagement with influential equity research analysts can drive institutional visibility and short-term stock price volatility.
+0.30The TULSA Procedure's CPT Category 1 codes became effective in January 2025, facilitating reimbursement. — Effective reimbursement codes are critical for commercial scaling and revenue growth in medical device companies.
+0.30Which stocks this story touches
Continue reading
6 related stories
Search tags
The company's TULSA procedure will be highlighted in multiple presentations and selected as one of only eight companies spotlighted at a major medical conference.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
4h ago
